TSPO imaging in parkinsonian disorders

Area of Science:

• Neuroscience
• Radiochemistry
• Medical Imaging

Background:

• Microglial activation is central to neuroinflammation in neurodegenerative disorders, including idiopathic and atypical parkinsonian disorders.
• Positron emission tomography (PET) enables in vivo imaging of microglial activation, correlating with neuropathological changes.
• PET has been used to demonstrate the effects of interventions targeting microglial activation in clinical trials.

Approach:

• Evaluating novel PET tracers for microglial activation with improved properties over [11C]-(R)-PK11195.
• Developing new PET tracers to target additional neuroinflammatory markers, such as astroglial function.
• Utilizing advanced imaging techniques to understand the role of neuroinflammation in disease progression.

Key Points:

• PET imaging reveals distinct patterns of microglial activation in parkinsonian disorders.
• Interventional studies using PET have shown the efficacy of treatments aimed at reducing neuroinflammation.
• Ongoing research focuses on developing superior PET tracers for more accurate and comprehensive neuroinflammation assessment.

Conclusions:

• PET is a valuable tool for studying neuroinflammation in neurodegenerative diseases.
• Development of new PET tracers will enhance our ability to diagnose and monitor these conditions.
• Future research will expand imaging capabilities to include other aspects of neuroinflammation, like astroglial function.